Phenylalanine HydroxylaseJanuary 2005 Molecule of the Month by Shuchismita Dutta and David Goodsell
doi: 10.2210/rcsb_pdb/mom_2005_1 (PDF Version, ePub Version )
The Protein Alphabet
The proteins that make up the skin, muscle, hair, bones and other organs in your body are primarily composed of a set of 20 building blocks, called amino acids. Amino acids are the alphabet in the protein language: when combined in a specific order, they make up meaningful structures (proteins) with varied and specific functions. Amino acids have distinct shapes, sizes, charges and other characteristics. Many amino acids are synthesized in your body from breakdown products of sugars and fats, or are converted from other amino acids by the action of specific enzymes. However, a few of them, called essential amino acids, cannot be synthesized or converted in your body and have to be obtained from the food you eat. Phenylalanine is one such essential amino acid. It is closely related to another amino acid, tyrosine, which just has an additional hydroxyl (OH) group. Liver cells contain an enzyme called phenylalanine hydroxylase, which can add this group and convert phenylalanine to tyrosine. Thus as long as this enzyme is functional and there is a reasonable supply of phenylalanine, tyrosine can be synthesized in your body and does not have to be included in the food that you eat.
Four molecules of phenylalanine hydroxylase interact to form a tetramer, which is the functional unit for this enzyme. Each molecule in the tetramer is organized into three domains: a regulatory domain, a catalytic domain where the enzyme activity resides and a tetramerization domain that assembles four chains into the tetramer. At the heart of each catalytic domain is an iron ion that plays an important role in the enzyme action. A model structure of the complete enzyme tetramer is shown here. This is composed of two PDB files: PDB entry 2pah, which includes the structure of the catalytic and tetramerization domains of the enzyme, and PDB entry 1phz, which includes the regulatory domain flexibly attached to the catalytic domain.
Surprisingly, we usually get too much phenylalanine in our diet, and this can cause problems. Normally, phenylalanine hydroxylase regulates the clearance of about 75% of the excess phenylalanine from our body by converting it to tyrosine. But in 1934, a Norwegian doctor, Asbjorn Folling, showed that the urine of two of his young mentally handicapped patients had a high level of phenylalanine. These were the first diagnosed cases of phenylketonuria. Within the next few years it was shown that the absence or malfunction of phenylalanine hydroxylase leads to this serious genetic disorder. However, it was not until the early 1950s that this information was put to use. A child suffering from phenylketonuria was treated with a diet low in the amino acid phenylalanine, showing that many of the symptoms of this disease could be reversed if treated early. Presently, in many places, newborn children are routinely screened for phenylketonuria and placed on a low phenylalanine diet if diagnosed. As these children grow up, they are also recommended to avoid the sweetener Aspartame, since it contains phenylalanine. In a few cases, lack of the tetrahydrobiopterin, an essential cofactor for the enzyme, or an inability to regenerate it can also lead to phenylketonuria. These cases may be treated with tetrahydrobiopterin supplements.
An Aromatic Alliance
The tyrosine synthesized by the action of phenylalanine hydroxylase is required
for the synthesis of various neurotransmitters that act on the nervous system and also
control key functions like respiration and heart rate. During the synthesis of these
neurotransmitters, tyrosine is further hydroxylated by the enzyme tyrosine hydroxylase.
Interestingly, phenylalanine hydroxylase (PDB entry 1pah, shown on the left) and
tyrosine hydroxylase (PDB entry 2toh, shown on the right) are structurally and
functionally very similar to each other and also to tryptophan hydroxylase (PDB entry
1mlw). The last enzyme acts on the related amino acid tryptophan. All three enzymes
use an iron ion, function as tetramers and have similar domain architecture. Since
phenylalanine, tyrosine and tryptophan all have aromatic ring structures, these
hydroxylases are together called aromatic amino acid hydroxylases.
For more information on phenylalanine hydroxylase from a genomic perspective, see the Protein of the Month at the European Bioinformatics Institute.
Exploring the Structure
The hydroxylation of phenylalanine requires free oxygen and a helper molecule
(cofactor), tetrahydrobiopterin. Although the exact mechanism of the enzyme action is
not known, it is clear that the cofactor interacts with a few conserved residues in the
enzyme and the primary function of the iron ion is to stabilize this cofactor. The
backbone structure of the catalytic domain of phenylalanine hydroxylase is shown here
(PDB entry 1j8u) with the tetrahydrobiopterin cofactor (colored green) and the iron ion
(yellow sphere). During the course of the reaction the cofactor loses two of its hydrogen
atoms to form dihydrobiopterin (as can be seen in PDB entry 1dmw). Yet another
enzyme acts on dihydrobiopterin to restore the original form of the cofactor, which is
then used in another cycle of hydroxylation.
Mutations in phenylalanine hydroxylase can block the conversion of phenylalanine to tyrosine. Several hundred mutations have been documented in this enzyme. Many of these mutations destroy the enzyme activity and lead to phenylketonuria. A few examples are shown here in red. These mutations disrupt the interaction of the enzyme with either the cofactor or the iron ion, reducing or stopping the enzyme activity. Other serious mutations (not shown here) are found in amino acids that stabilize the structure of the enzyme, on the face that forms the enzyme tetramer or in regions that interact with the regulatory domain.
This illustration was created with RasMol. You can create similar pictures of phenylalanine hydroxylase by clicking on the accession codes here, and picking one of the options under View Structure.
Further information on phenylalanine hydroxylase
Erlandsen, H. and Stevens, R.C. (1999) The structural basis of phenylketonuria. Molecular
Genetics and Metabolism 68, 103-25.
Phenylalanine Hydroxylase Locus Knowledgebase web site (http://www.pahdb.mcgill.ca/)
© 2013 David Goodsell & RCSB Protein Data Bank